Cargando…
Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
Anti-VEGF drugs like ranibizumab can be used to treat retinopathy of prematurity (ROP) by halting the formation of abnormal blood vessels, or lasers can be used to burn the edges of the retina where these vessels are present. The objective is to compare the efficacy for ROP between ranibizumab and l...
Autores principales: | Alva, Niza, Martínez, Alex R., Ortiz-Saavedra, Brando, Montes-Madariaga, Elizbet S., Cotrina, Alonso, Caballero-Alvarado, José A., Sah, Ranjit, Barboza, Joshuan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436596/ https://www.ncbi.nlm.nih.gov/pubmed/37601137 http://dx.doi.org/10.3389/fped.2023.1202927 |
Ejemplares similares
-
Epidemiologic Situation of HIV and Monkeypox Coinfection: A Systematic Review
por: Ortiz-Saavedra, Brando, et al.
Publicado: (2023) -
Antiviral Treatment against Monkeypox: A Scoping Review
por: Ortiz-Saavedra, Brando, et al.
Publicado: (2022) -
Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016) -
Effect of ranibizumab on retinopathy of prematurity: A meta-analysis
por: Wang, Zhibin, et al.
Publicado: (2022) -
Immune responses in COVID-19 and tuberculosis coinfection: A scoping review
por: Flores-Lovon, Kevin, et al.
Publicado: (2022)